08:00 , Dec 3, 2012 |  BC Week In Review  |  Company News

AptarGroup management update

AptarGroup Inc. (NYSE:ATR), Crystal Lake, Ill.   Business: Drug delivery   Transitioned: Jean-Marc Pardonge to president of AptarGroup's Aptar Pharma prescription division and general manager of AptarGroup's Aptar Stelmi subsidiary from president of Aptar Pharma's...
08:00 , Nov 21, 2011 |  BC Week In Review  |  Company News

Oval Medical, AptarGroup deal

Oval Medical granted AptarGroup a license to IP. AptarGroup's Aptar Pharma unit will have access to Oval Medical's IP in undisclosed therapeutic areas for R&D. Oval Medical, which is developing auto-injector technology for drug delivery,...
08:00 , Nov 21, 2011 |  BC Week In Review  |  Financial News

Oval Medical completes venture financing

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery   Date completed: 11/16/11   Type: Venture financing   Raised: £2 million ($3.2 million)   Investor: AptarGroup  ...
07:00 , Jun 24, 2002 |  BC Week In Review  |  Company News

AptarGroup Inc., Wyeth deal

Valois S.A.S. (Marly-le-Roi, France), a subsidiary of ATR, exclusively licensed its Combidose intra-nasal drug delivery system to WYE for use in the pharma company's therapeutic and prophylactic vaccines. Valois will receive an upfront fee, annual...
07:00 , Jun 17, 2002 |  BC Extra  |  Company News

Valois, Wyeth intranasal delivery deal

Valois (Marly-le-Roi, France), a subsidiary of AptarGroup (ATR), exclusively licensed its Combidose intra-nasal drug delivery system for use with WYE's therapeutic and prophylactic vaccines. Valois will receive an up-front fee, annual fees until a product...